Drug Design: From Development to Commercialization
Nucleate Norway, with support from Digital Life Norway, offers this course on drug design—from early planning to market launch. Participants will learn to evaluate risks and benefits, navigate regulations in Norway and internationally, and connect with industry professionals. The course also highlights opportunities for Norwegian researchers to develop medical products and grow their businesses.
The key outcomes and impacts will be:
· Recognize the interaction between strategy and research and understand how they influence each other in drug development.
· Apply frameworks to assess risks and benefits associated with introducing new healthcare products to the market.
· Understand regulatory requirements for product approval in both Norwegian and international markets.
· Identify opportunities for Norwegian researchers to advance drug development and grow their businesses.
· Build a professional network with scientists, entrepreneurs, and industry experts to support career development and strategic partnerships.
· Learn from leading experts in drug discovery, gaining insights from their experience and practical knowledge in the field.
Target audience:
The course is designed to welcome a broad spectrum of participants interested in drug discovery, including master's students, PhD candidates, and postdoctoral researchers. To ensure a strong foundation for all attendees, participants are required to have a degree in biology or a related field and should have a keen interest in the commercialization of scientific research. This inclusive approach aims to foster a collaborative learning environment where individuals at different stages of their academic and professional journeys can engage with the latest developments in the field.
The detailed program, including the list of speakers, will be updated later.
The number of places for these courses is limited. The applications will be processed, and final acceptances will be reported.
Contact email: alexandera@nucleate.org